Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence A Stern

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioconjugate Chemistry|March 15, 2018
Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic ReceptorsClifford M Csizmar, Jacob R Petersburg, Alex Hendricks, et al.
ACS Combinatorial Science|January 9, 2019
Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276Lawrence A Stern, Patrick S Lown, Alexandra C Kobe, et al.
Biotechnology and Bioengineering|May 5, 2016
Geometry and expression enhance enrichment of functional yeast-displayed ligands via cell panningLawrence A Stern, Ian A Schrack, Sadie M Johnson, et al.
Blood Neoplasia|June 24, 2025
Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignanciesLawrence A Stern, Vibhuti Vyas, Laura Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2020
Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer DetectionRakesh Bam, Patrick S Lown, Lawrence A Stern, et al.
Molecular Therapy. Oncology|June 28, 2024
Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cellsKelly T Kennewick, Yukiko Yamaguchi, Jackson Gibson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2022
Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapyLawrence A Stern, Sharareh Gholamin, Ignacio Moraga, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T CellsCheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Biorxiv : the Preprint Server for Biology|May 23, 2025
Solid tumor CAR T cells engineered with fusion proteins targeting PDL1 for localized IL-12 deliveryJohn P Murad, Lea Christian, Reginaldo Rosa, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, Cody Cullen, John P Murad, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioconjugate Chemistry|March 15, 2018
Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic ReceptorsClifford M Csizmar, Jacob R Petersburg, Alex Hendricks, et al.
ACS Combinatorial Science|January 9, 2019
Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276Lawrence A Stern, Patrick S Lown, Alexandra C Kobe, et al.
Biotechnology and Bioengineering|May 5, 2016
Geometry and expression enhance enrichment of functional yeast-displayed ligands via cell panningLawrence A Stern, Ian A Schrack, Sadie M Johnson, et al.
Blood Neoplasia|June 24, 2025
Development and characterization of a low-affinity humanized CD19 chimeric antigen receptor for B-cell malignanciesLawrence A Stern, Vibhuti Vyas, Laura Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2020
Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer DetectionRakesh Bam, Patrick S Lown, Lawrence A Stern, et al.
Molecular Therapy. Oncology|June 28, 2024
Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cellsKelly T Kennewick, Yukiko Yamaguchi, Jackson Gibson, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2022
Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapyLawrence A Stern, Sharareh Gholamin, Ignacio Moraga, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T CellsCheng-Fu Kuo, Zhen Tong, Yi-Chiu Kuo, et al.
Biorxiv : the Preprint Server for Biology|May 23, 2025
Solid tumor CAR T cells engineered with fusion proteins targeting PDL1 for localized IL-12 deliveryJohn P Murad, Lea Christian, Reginaldo Rosa, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targetingEric Hee Jun Lee, Cody Cullen, John P Murad, et al.
Pageof 3